Login
$PFAI
$3.90 +$0.35 (9.86%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q4 FY2024
As of Dec 31, 2024
Assets
Current Assets
Cash
Inventories
Accounts receivable (net of allowance for credit losses of US$245,753 and US$90,281 at December 31, 2025 and 2024, respectively)
Prepaid expenses
Loan receivable
Other receivables
Total current assets
Non-current assets
Property, plant and equipment, net
Right-of-use assets – operating leases
Intangible assets, net
Deposits
Deferred offering costs
Total assets
Liabilities:
Current liabilities
Accounts payable and accrued liabilities
Accrued payroll liabilities
Income taxes payable
Due to related parties
Contract liabilities
Bank loan, current portion
Operating lease liabilities, current portion
Other payables
Promissory note
Total current liabilities
Non-current liabilities
Bank loan, non-current portion
Operating lease liabilities, non-current portion
Deferred tax liabilities
Total liabilities
Subsidiary’s preferred shares subject to redemption
Stockholders’ equity
Common stock value
Additional paid-in capital
Subscription receivable
Accumulated other comprehensive income
Retained earnings (deficit)
Total stockholders’ equity
Total liabilities, subsidiary’s preferred shares subject to redemption and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support